CSIMarket
 

Rxsight Inc   (NASDAQ: RXST)

Rxsight Inc 's

Competitiveness




 

RXST Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Rxsight Inc reported Revenue decrease in the 1 quarter 2026 year on year by -18.3 %, despite the revenue increase by the most of its competitors of 9.12 %, recorded in the same quarter.

List of RXST Competitors





Revenue Growth Comparisons




Net Income Comparison


Rxsight Inc , slower than the average decrease reported by the company's competitors of -38.77 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -38.77 %

<<  RXST Stock Performance Comparisons



  

Overall company Market Share Q1 2026

Overall company, revenue fell by -18.3 % and company lost market share, to approximately 0.08 %.




<<  More on RXST Market Share.
 
*Market share is calculated based on total revenue.

  News about Rxsight Inc Contracts

RxSight, Inc. Faces Class Action Amid Improved Financial Metrics A Dual Perspective on Market Confidence

September 15, 2025
In recent weeks, shareholders of RxSight, Inc. (NASDAQ: RXST) have found themselves in a complex financial landscape as news of a securities class action has been announced. The Rosen Law Firm, a globally recognized firm specializing in investor rights, has issued a reminder to investors regarding an important lead plaintiff deadline of September 22, 2025. This announcement arrives concurrently with RxSight s financial performance in the second quarter of 2025, which has shown improvement in certain metrics despite the looming legal concerns. Class Action Lawsuit The notification from the Rosen Law Firm emphasizes the need for investors who purchased securities of RxSight between November 7, 2024, and July ...





Publicly Traded Peers of Rxsight Inc




Alcon inc
Share Performance



-8.30%
One Year



Alcon inc
Profile

Alcon Inc's business model revolves around providing advanced eye care products and services, including pharmaceuticals, surgical equipment, and vision care solutions.

More about Alcon inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 35,612.274 mill. $ 12,997.000 mill. $ 1,156.000 mill.


Bausch and Lomb Corp
Share Performance



+13.23%
This Quarter



Bausch and Lomb Corp
Profile

Bausch and Lomb Corp's business model revolves around developing and manufacturing eye health products and vision care solutions.

More about Bausch and Lomb Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6,327.812 mill. $ 5,324.000 mill. $ -163.000 mill.


The Cooper Companies Inc
Share Performance



-4.88%
Over The Past 5 Days



The Cooper Companies Inc
Profile

The Cooper Companies Inc is a global medical device firm focused on manufacturing and distributing contact lenses and womens healthcare products. Its business model emphasizes innovation, strong distribution, strategic acquisitions, and partnerships to enhance market presence, targeting the specific needs of customers in eye care and womens health. Through research and development, they aim to improve customer lives while maximizing shareholder value.

More about The Cooper Companies Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13,547.625 mill. $ 4,230.400 mill. $ 235.800 mill.


National Vision Holdings Inc
Share Performance



-34.07%
This Year



National Vision Holdings Inc
Profile

National Vision Holdings Inc is a leading retailer of eyewear and optical products in the United States. The company operates a vertically integrated business model, which involves manufacturing, marketing, and distributing a wide range of eyewear products through its branded retail stores and third-party retail locations. National Vision Holdings Inc focuses on offering affordable and accessible vision care solutions to customers by leveraging its supply chain and retail network capabilities.

More about National Vision Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,394.328 mill. $ 2,021.044 mill. $ 46.595 mill.


Johnson and Johnson
Share Performance



+29.65%
This Year



Johnson and Johnson
Profile

Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.

More about Johnson and Johnson's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 655,958.418 mill. $ 97,929.000 mill. $ 21,037.000 mill.

8 more competitors available

Sign in to see all competitors

Sources: Rxsight Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Rxsight Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.